nivolumab,ipilimumab
bms
['improve ', 'ipiniv', 'cm-914', 'rcc,(-irccs),(-srcc),(-urcc)', 'nivo']
cm-914: adjuvant ipinivo in resected rcc. fails to improve dfs, with significant toxicity. another negative trial in this setting. #esmo22 
Medical Oncologist - Urologic Oncology. Hospital Universitario La Paz - IdiPAZ, Madrid